Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 39, Issue 25, Pages 2803-2815
Publisher
American Society of Clinical Oncology (ASCO)
Online
2021-06-03
DOI
10.1200/jco.20.03611
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.
- (2020) Howard Safran et al. JOURNAL OF CLINICAL ONCOLOGY
- The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies
- (2019) Tao Wang et al. Drug Design Development and Therapy
- Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
- (2018) B Sunde et al. DISEASES OF THE ESOPHAGUS
- Surrogate end-points for overall survival in 22 neoadjuvant trials of gastro-oesophageal cancers
- (2017) Fausto Petrelli et al. EUROPEAN JOURNAL OF CANCER
- NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
- (2017) Somnath Mukherjee et al. EUROPEAN JOURNAL OF CANCER
- Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer
- (2015) Ta-Chen Huang et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
- (2015) Joel Shapiro et al. LANCET ONCOLOGY
- A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer
- (2013) J. A. Ajani et al. ANNALS OF ONCOLOGY
- Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
- (2012) P. van Hagen et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
- (2011) Nobutoshi Ando et al. ANNALS OF SURGICAL ONCOLOGY
- Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer
- (2011) David H. Ilson et al. CANCER
- S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarcinoma
- (2011) Lawrence P. Leichman et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-FDG PET-Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial
- (2011) C. Meyer zum Buschenfelde et al. JOURNAL OF NUCLEAR MEDICINE
- Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781
- (2008) Joel Tepper et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started